Connect Biopharma (CNTB) Earnings Date, Estimates & Call Transcripts $0.98 -0.06 (-5.34%) Closing price 06/23/2025 03:50 PM EasternExtended Trading$1.01 +0.03 (+3.49%) As of 06/23/2025 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Connect Biopharma Earnings Summary Connect Biopharma issued Q1 2025 earnings on May 15, 2025, reporting an EPS of -$0.19, which topped analysts' consensus estimates of -$0.26 by $0.07. With a trailing EPS of $0.00, Connect Biopharma's earnings are expected to decrease next year, from ($0.22) to ($0.32) per share. Upcoming Q2 Earnings DateSep. 5Before Market OpensEstimatedConsensus EPS (May. 15) -$0.26 Actual EPS (May. 15) -$0.19 Beat By $0.07 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)CNTB Upcoming EarningsConnect Biopharma's next earnings date is estimated for Friday, September 5, 2025, based on past reporting schedules. Powered by Get Connect Biopharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Connect Biopharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Connect Biopharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.26-$0.26-$0.26Q2 20251-$0.22-$0.22-$0.22Q3 20251-$0.23-$0.23-$0.23Q4 20251-$0.27-$0.27-$0.27 Connect Biopharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 9/5/2025(Estimated)--------5/15/2025--$0.26-$0.19+$0.07-$0.19-- Connect Biopharma Earnings - Frequently Asked Questions When is Connect Biopharma's earnings date? Connect Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, September 5th, 2025 based off last year's report dates. Learn more on CNTB's earnings history. Did Connect Biopharma beat their earnings estimates last quarter? In the previous quarter, Connect Biopharma (NASDAQ:CNTB) reported ($0.19) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.26) by $0.07. Learn more on analysts' earnings estimate vs. CNTB's actual earnings. How much revenue does Connect Biopharma generate each year? Connect Biopharma (NASDAQ:CNTB) has a recorded annual revenue of $26.03 million. How much profit does Connect Biopharma generate each year? Connect Biopharma (NASDAQ:CNTB) has a recorded net income of -$15.63 million. CNTB has generated $0.00 earnings per share over the last four quarters. What is Connect Biopharma's EPS forecast for next year? Connect Biopharma's earnings are expected to decrease from ($0.22) per share to ($0.32) per share in the next year. More Earnings Resources from MarketBeat Related Companies BTMD Earnings Date INBX Earnings Date MNPR Earnings Date SCPH Earnings Date IMAB Earnings Date CRGX Earnings Date FDMT Earnings Date PRQR Earnings Date DRUG Earnings Date KOD Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs This page (NASDAQ:CNTB) was last updated on 6/24/2025 by MarketBeat.com Staff From Our PartnersIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | Sponsored12 “perfect” stocksJoin the Dream Team and see how we can guarantee stock market wins Credentials are a good thing, especiall...Zacks | SponsoredHow high will gold surge? Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and de...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Connect Biopharma Holdings Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Connect Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.